HA Filler vs. PMMA for Penile Girth: Reversible vs. Permanent, Honestly Compared

What each product actually is

Hyaluronic acid (HA)

Hyaluronic acid is a sugar molecule your body already produces — it lubricates joints and hydrates skin. HA dermal fillers are cross-linked HA gels, FDA-approved for facial folds and volumes. Their use in the penis is off-label, which is lawful when a licensed physician performs it. HA fillers are gel-like, integrate with tissue, and are dissolved on demand by an enzyme called hyaluronidase. WIDR uses HA blended with a proprietary Placental Protein Matrix; the blend and its limits are explained at consultation.

Polymethylmethacrylate (PMMA)

PMMA is the same material used in bone cement and Plexiglas — a non-absorbable synthetic polymer. In cosmetic use, PMMA microspheres are suspended in a collagen or gel carrier. After injection, the carrier dissolves and the body forms a fibrous capsule around the microspheres. That capsule is what makes the volume permanent. FDA-approved PMMA products (such as Bellafill) are cleared for facial folds and acne scars. Penile use is off-label. No enzyme dissolves PMMA once placed.

The category you'll also hear about

Some clinics market "permanent" or "semi-permanent" fillers under proprietary names — LorFill, Platinum, and similar. These are typically PMMA-based or use other non-absorbable polymers. If a clinic advertises "one-and-done" or "lifetime" results from an injection, you are looking at a permanent-filler product regardless of the brand name.

Complication profiles, honestly

Both products can produce excellent results in skilled hands. The difference is what happens when they don't.

HA filler

• Swelling and bruising: Expected, resolves in days to a week.
• Uneven distribution, small lumps, migration: Uncommon; correctable by adjusting or dissolving the specific area.
• Vascular events: Rare. Risk is meaningfully reduced by ultrasound-assisted anatomy mapping and blunt cannula placement.
• Overall complication rate in peer-reviewed reviews: Typically reported below 5% for HA-based penile augmentation.

PMMA

• Surface irregularities: Reported in up to 52% of patients in some published series — the material's texture makes evenness harder to achieve and impossible to soften after placement.
• Granulomas and nodules: Foreign-body reactions can form months to years after placement, sometimes requiring biopsy or excision.
• Migration and displacement: Late migration is documented; because the material cannot be dissolved, correction is surgical.
• Severe complications: The peer-reviewed literature includes case reports of urethral compromise, glans necrosis, and scrotal flap reconstruction after PMMA-related complications. These are not the common outcome, but they exist — and they are the ceiling of what can go wrong.

Every number here depends on the injector, the volume, the anatomy, and whether imaging was used. But the shape of the difference is consistent across the medical literature: HA has a lower complication rate and, more importantly, a fundamentally different response when a complication does occur.

The reversibility question

Reversibility is not a marketing feature. It is the single most consequential difference between these two products.

If an HA result is uneven — a small lump on one side, more volume than the patient wanted, migration into an area it shouldn't have — an injection of hyaluronidase dissolves the problem, usually within 24 to 72 hours. If the patient changes his mind entirely, a series of hyaluronidase sessions returns the tissue to its starting state. The total time cost is days. The financial cost is a follow-up visit.

If a PMMA result is uneven, there is no enzyme. The correction options are (1) inject more PMMA to smooth the irregularity, adding permanent material to a permanent problem, or (2) surgical excision, which in advanced cases has required scrotal skin flaps or grafts to close. The total time cost is weeks to months of recovery. The financial cost is a second procedure billed at surgical rates.

Every man asking about girth enhancement should ask himself the same question: if this goes wrong, what is my exit? With HA, the exit is a syringe. With PMMA, the exit is an operating room.

Why "permanent" is often the risk, not the feature

Clinics marketing PMMA lean on one line: "get it once, keep it forever." That framing works because it maps onto how patients think about other cosmetic decisions — a permanent solution sounds like a good solution.

The clinical reality is different for two reasons.

Bodies change. Preferences change. Tissue thins with age. Weight fluctuates. What looked balanced at 35 may look overdone at 55. HA gives you a natural exit point every 12 to 24 months. PMMA gives you the same result at 55 that you chose at 35, whether you still want it or not.

Technique varies more than products do. Even a well-formulated product placed by a mediocre injector produces mediocre results. With HA, mediocre becomes an opportunity to adjust. With PMMA, mediocre becomes permanent.

Permanence, in a procedure where injector skill varies this much between providers, is not a feature. It is a bet that everything will go right the first time, and that the version of you who chose it at 35 will still be the version of you who wants it at 55. Both bets can be wrong.

Cost, over 5 to 10 years

PMMA marketing often frames the cost comparison as "pay once vs. pay every year." That framing ignores three things: the initial price is not lower, most patients need more than one PMMA session to reach a goal, and any surgical revision costs the same as (or more than) the original procedure.

The honest headline: at 5–10 years, HA and PMMA can total similar amounts of money if PMMA goes perfectly. If it doesn't, PMMA is more expensive — and the added cost is a surgery, not a syringe. WIDR's full pricing is here, including multi-session bundles.

Who might still choose PMMA

Part of being honest about this comparison is naming the small set of patients for whom the trade-off may genuinely tilt toward a permanent filler. It's a short list.

• A patient with a clear, long-standing goal, no expectation of change, and a documented history of good outcomes with the specific injector using the specific product.
• A patient who has already tried HA, achieved his goal, and now wants a long-term hold — treating permanence as an informed choice rather than a marketing hook.
• A patient outside the United States, where PMMA products in aesthetic use have longer track records and stricter provider regulation in some jurisdictions.

For everyone else — the man in his 30s or 40s researching this for the first time, considering a $5,000–$8,000 decision, without a specific injector already in mind — HA is the more conservative starting point. If it works and you love it, it also works next year, and the year after, and you keep the ability to adjust.

Frequently asked questions

Weighing HA against a permanent product? Book a video consultation — a private 20–30 minute call with the WIDR physician, $100 credited toward treatment. Come with the specific product name; you'll leave with a straight answer. See how safety actually breaks down and why WIDR uses ultrasound and cannula.